Nationwide Fund Advisors’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-20,367
Closed -$24K 2597
2017
Q3
$24K Hold
20,367
﹤0.01% 3099
2017
Q2
$35K Hold
20,367
﹤0.01% 3083
2017
Q1
$54K Sell
20,367
-3,009
-13% -$10.8K ﹤0.01% 2970
2016
Q4
$99K Hold
23,376
﹤0.01% 2879
2016
Q3
$62K Hold
23,376
﹤0.01% 3019
2016
Q2
$41K Sell
23,376
-21,500
-48% -$43.9K ﹤0.01% 3102
2016
Q1
$104K Buy
44,876
+21,500
+92% +$48.6K ﹤0.01% 2803
2015
Q4
$81K Hold
23,376
﹤0.01% 2909
2015
Q3
$143K Hold
23,376
﹤0.01% 2739
2015
Q2
$154K Buy
23,376
+6,204
+36% +$41.8K ﹤0.01% 2851
2015
Q1
$122K Buy
+17,172
New +$130K ﹤0.01% 2914

Other funds holding GEN

Nationwide Fund Advisors's GEN Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Genesis Healthcare, Inc. (GEN) in Q4 2017, closing a stake of 20,367 shares — an estimated $24K sold.

Nationwide Fund Advisors first reported a position in GEN in Q1 2015 and held it in 11 quarters. The position peaked at $154K in Q2 2015. 68 funds tracked by Wall St. Rank hold GEN as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Genesis Healthcare, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 20,367 Genesis Healthcare, Inc. shares in Q4 2017, an estimated $24K.
  • Nationwide Fund Advisors first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 11 quarters.
  • Nationwide Fund Advisors's Genesis Healthcare, Inc. position peaked at $154K in Q2 2015.
  • 68 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.